The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make ...

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet ...

The facility is part of the company’s commitment, earlier this year, to invest $23 billion in the U.S. over the next five ...

Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...

Novartis, a global innovative medicines company, has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, CA.

Novartis invests $23B in U.S. infrastructure, opening a new Carlsbad facility and expanding radioligand therapy sites. Read ...

Secondary endpoints “indicate symptom reduction and patient benefit beyond improvement in disease activity,” according to ...

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...

Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter, dragging the Swiss company's shares lower, as its top-selling drug comes under pressure from cheaper ...

Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the matter.

Novartis opens new radioligand therapy manufacturing facility in California as part of $23 billion US expansion plan: Basel Wednesday, November 12, 2025, 10:00 Hrs [IST] Novartis, ...